Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2009
12/15/2009US7633604 Sample analyzer and computer program product
12/15/2009US7632931 Endogeneous nucleic acid fragment associated with an autoimmune disease, labeling method and reagent
12/15/2009US7632929 hapten compounds comprising either methamphetamine or amphetamine conjugated to a linker; therapy for drug overdose, decreases the concentration of methamphetamine, amphetamine, or MDMA in the brain of the subject
12/15/2009US7632922 Osteoprotegerin
12/15/2009US7632825 Methods of decreasing or preventing pain using spicamycin derivatives
12/15/2009US7632819 Administering a peptide, Asparagine-Isoleucine-Proline-Asparagine (SEQ ID NO: 5),to inhibit oxidative stress mediating neurodegenerative diseases; antiapoptosis; Alzheimer's, Parkinson's, and Huntington diseases; amyotrophic lateral sclerosis;antiischemic, -inflammatory agents; stroke, cardiovascular
12/15/2009US7632815 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals
12/15/2009US7632801 Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
12/15/2009US7632688 magnetic substance-encapsulated particle contains iron oxide substance being dispersed and encapsulated within a crosslinked polymer/shell-core/ material; capable of forming a covalent bond with antigen or antibody; uniform magnetism, high dispersion stability and a narrow particle size distribut
12/15/2009US7632687 Hybrid phase lateral flow assay
12/15/2009US7632686 High sensitivity quantitation of peptides by mass spectrometry
12/15/2009US7632685 analysis an individual sample and compare with a reference biomarker profile; accurate, rapid, and sensitive method; determine an individual at risk of developing sepsis
12/15/2009US7632684 Assay of isomerised and/or optically inverted proteins and protein fragments
12/15/2009US7632683 staining the yeast-like fungi with a fluorescent dye, detecting with light irradiation; detecting urine sample; determining the presence or absence of bleeding in a path from the glomerulus of a kidney to the urethra; analysis; diagnosis
12/15/2009US7632674 Apparatus for stimulating an animal cell and recording its physiological signal and production and use methods thereof
12/15/2009US7632671 Detecting trace quantities of a molecular target by exploiting a specific interaction between the target and two molecular probes; identifying restriction fragment length polymorphisms; gene expression analysis
12/15/2009US7632670 biosensor used in DNA, RNA analysis, detecting antigens and substrates of immobilized enzymes; detected by detecting the modified voltage in the transistor
12/15/2009US7632661 Expression elements
12/15/2009US7632656 analysis; measuring the amount of drug metabolized by a specific drug metabolizing enzyme; temperature responsive crosslinked polymer is polyisopropyl acrylamide and/or polydiethyl acrylamide, or a copolymerization product thereof; diagnostic method for cirrhosis and/or liver cancer
12/15/2009US7632654 Chitinase, lysozyme, heparanase, hyaluronidase, and cellulase; competitive inhibitors; kits
12/15/2009US7632653 Membrane-based assay devices that utilize time-resolved fluorescence
12/15/2009US7632652 Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences
12/15/2009US7632651 Molecular modification assays
12/15/2009US7632650 Diagnostics and therapeutic uses of topors
12/15/2009US7632649 In vitro; transcription factors; competitive binding; ELISA; immunoassay; immunohistochemistry
12/15/2009US7632648 Screening a library of potential specific binders with at least one cyclic peptide for identifying specific binding partners for holoTC, having specificity for holoTC over apoTC of at least 40-fold
12/15/2009US7632647 Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
12/15/2009US7632646 Tuberculosis diagnostic test
12/15/2009US7632645 High throughput screening; signal transduction
12/15/2009US7632644 Imaging and selective retention of phospholipid ether analogs
12/15/2009US7632643 PCA3, PCA3 genes, and methods of use
12/15/2009US7632638 Particles coated with capture agent having affinity for virus form complex; flexural plate wave devices; food safety
12/15/2009US7632635 Method for measuring resistance of a patient HIV-2 to protease inhibitors
12/15/2009US7632633 Method for determining the degree of protein oxidation in a skin sample using oxidized protein in stratum corneum as an indicator
12/15/2009US7632548 Exposing a chemical species to nanoparticles such that chemical species adsorbs onto a surface of the nanoparticles; irradiating; detecting altered photoluminescence properties of the nanoparticles comprising chemical adsorbate; analyzing
12/15/2009US7632516 Moraxella catarrhalis BASB115 polypeptides
12/15/2009US7632510 Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence
12/15/2009US7632507 Comprises nucleotide sequences coding synoviolin polypeptide for identifying modulators for treatment of arthritic and inflammatory disorders
12/15/2009US7632504 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/15/2009US7632502 Immunoglobulin for diagnosis and prevention of yeast infections
12/15/2009US7632498 MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
12/15/2009US7632497 Molecules having a variant Fc region, wherein region comprises at least one amino acid modification relative to a wild-type Fc region; modified molecules confer an effector function to a molecule, where the parent molecule does not detectably exhibit this effector function; utility in cancer treatment
12/15/2009US7632486 Efficacy of drugs in the treatment of malignant tumors such as breast cancer, prostatic cancer and lung cancer that cause the bone metastasis are diagnosed using a marker that reflects the activity of osteoblasts and a marker that reflects the action of osteoclasts
12/15/2009US7632468 Retaining clip for reagent test slides
12/15/2009US7632462 Assay system
12/15/2009US7632461 In situ heat induced antigen recovery and staining apparatus and method
12/15/2009US7632460 Useful for determining qualitatively or quantitatively the presence of one or more analytes in a fluid sample; means to facilitate the correct interaction between an analyzer and a reader; ' lock-and-key' interaction
12/15/2009US7632393 Total organic carbon (TOC) analyzer
12/15/2009US7631543 Method and apparatus for measuring the composition and water salinity of a multiphase mixture containing water
12/15/2009US7631538 Method and equipment for measuring vapour flux from surfaces
12/15/2009CA2497295C Single phase sampling apparatus and method
12/15/2009CA2462737C Apparatus and method for concurrently monitoring active release and physical appearance of solid dosage form pharmaceuticals
12/15/2009CA2421907C A screening method for a substance having hypoglycemic activity by using stat-induced inhibitor of stat function-1
12/15/2009CA2308604C Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
12/15/2009CA2276306C Loss of imprinting-based in vitro diagnostic method to determine the propensity to develop cancer
12/15/2009CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof
12/15/2009CA2243088C Humanized green fluorescent protein genes and methods
12/13/2009CA2727818A1 Characterization of biological samples
12/10/2009WO2009149467A2 Method and system for concentrating particles from a solution
12/10/2009WO2009149359A2 Survival predictor for diffuse large b cell lymphoma
12/10/2009WO2009149328A2 Methods and instrumentation for during-synthesis monitoring of polymer functional evolution
12/10/2009WO2009149319A2 Gene expression profiles associated with asthma exacerbation attacks
12/10/2009WO2009149308A2 Compositions and methods for rapid one-step diagnosis
12/10/2009WO2009149305A2 Method for creating distinct nitrocellulose-based pads on a substrate
12/10/2009WO2009149297A1 Diffuse large b-cell lymphoma markers and uses therefor
12/10/2009WO2009149293A1 Rapid detection of post-vaccination antibody response
12/10/2009WO2009149266A2 Noninvasive measurement of carotenoids in biological tissue
12/10/2009WO2009149257A1 The chemistrode: a plug-based microfluidic device and method for stimulation and sampling with high temporal, spatial, and chemical resolution
12/10/2009WO2009149203A1 Detecting infection in reduced pressure wound treatment
12/10/2009WO2009149193A1 User interface for testing device
12/10/2009WO2009149091A1 Controllable assembly and disassembly of nanoparticle systems via protein and dna agents
12/10/2009WO2009149087A2 Method for distinguishing between kidney dysfunctions
12/10/2009WO2009148970A1 Salivary biomarkers for sjögren's syndrome
12/10/2009WO2009148958A1 Biomarker for assessing response to chymase treatment
12/10/2009WO2009148927A2 Assays for performance of organisms in phenotrons
12/10/2009WO2009148915A2 Methods for predicting patient response to modulation of the co-stimulatory pathway
12/10/2009WO2009148896A2 Anti-phospho-akt antibodies
12/10/2009WO2009148669A1 Method for predicting skin sensitizing activity of compounds
12/10/2009WO2009148628A2 Tyrosine phosphorylation sites in tnk1 kinase
12/10/2009WO2009148608A1 Screening methods for heat-shock response modulators
12/10/2009WO2009148528A2 Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
12/10/2009WO2009148527A2 Mass spectrometer output analysis tool for identification of proteins
12/10/2009WO2009148470A1 Methods for diagnosing bowel disease
12/10/2009WO2009148406A1 Immunoassay
12/10/2009WO2009148396A1 Concentration assay
12/10/2009WO2009148395A1 Method for virus detection
12/10/2009WO2009148363A2 Method for diagnosing parasitic disease
12/10/2009WO2009148184A1 Method for detection of idiopathic interstitial pneumonia
12/10/2009WO2009148150A1 Device for detection of influenza virus
12/10/2009WO2009148132A1 Method of assaying physiologically active substance of biological origin, kit for assaying physiologically active substance of biological origin and apparatus for assaying physiologically active substance of biological origin
12/10/2009WO2009148050A1 Method of evaluating effects of relieving and preventing arteriosclerosis, kit for the evaluation and method of screening substance
12/10/2009WO2009147999A1 IgA NEPHROPATHY DETECTION METHOD AND DETECTION KIT
12/10/2009WO2009147998A1 IgA NEPHROPATHY DETECTION METHOD AND DETECTION KIT
12/10/2009WO2009147742A1 Sirna of human osteopontin
12/10/2009WO2009147549A1 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging
12/10/2009WO2009147511A1 Method and device for measuring the purity of ultrapure water
12/10/2009WO2009147504A1 Composition for the colorimetric detection and/or determination of metal cations in solution, reaction column, flow cell and method for the colorimetric detection and/or determination of metal cations in solution
12/10/2009WO2009147437A1 Assay reader, device and method for measuring hcg
12/10/2009WO2009147352A2 Device for detecting at least one element contained in a blood solution
12/10/2009WO2009147244A1 Method and device using nanoporous membrane for detecting and quantifying heavy metal ions in a fluid by anodic stripping voltammetry